Teva Pharmaceutical has proposed to acquire drug maker Mylan for about $40 billion in cash and stock, a sign of the jockeying for dominance among generic drug makers.

Sections:  world   
Topics:  asia   
RELATED ARTICLES
BING NEWS:
  • 3 Spectacular High-Yield Dividend Stocks to Buy in November
    Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
    11/10/2024 - 2:15 am | View Link
  • 3 'Must-Buy' Growth Stocks At Bargain Prices This November
    Despite relatively high valuations, few high-quality stocks have sold off recently. Click here for 3 'must-buy' growth stocks at bargain prices this November.
    11/10/2024 - 12:15 am | View Link
  • Elanco Animal Health (ELAN) Gets a Buy from Stifel Nicolaus
    In a report released today, Jonathan Block from Stifel Nicolaus maintained a Buy rating on Elanco Animal Health (ELAN ... manufacture and market products for companion and food animals. It offers ...
    11/7/2024 - 7:40 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News